ORPHAN DRUG REIMBURSEMENT IN ENGLAND AND IMPLICATIONS FOR PATIENT ACCESS

被引：0

|

作者：

Walker, S. ^{[1
]}

Lilley, H. ^{[1
]}

Payne, R. ^{[1
]}

Fountain, D. ^{[1
]}

机构：

[1] PHMR Ltd, London, England

来源：

VALUE IN HEALTH | 2019年 / 22卷

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PRO101

引用

收藏

页码：S859 / S859

页数：1

相关论文

共 50 条

[1] Orphan drugs: pricing, reimbursement and patient access
Barak, Adam
Nandi, Jyoti Shankar
[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING, 2011, 5 (04) : 299 - 317
[2] IS EU ORPHAN MEDICINE STATUS WORKING? A RETROSPECTIVE ANALYSIS OF ORPHAN DRUG REIMBURSEMENT IN ENGLAND
Coyle, S.
Mumford, J.
Roberts, G.
[J]. VALUE IN HEALTH, 2020, 23 : S704 - S704
[3] CHANGING LANDSCAPE OF ORPHAN DRUG REIMBURSEMENT - EVIDENCE FROM EU-4 AND ENGLAND
Foxon, G.
Tokarska, J.
Debevec, D.
Guillot, M.
Lizan, L.
Prada, M.
Vollmer, L.
[J]. VALUE IN HEALTH, 2022, 25 (12) : S235 - S235
[4] ORPHAN DRUG ACCESS AND REIMBURSEMENT IN THE EU5: CYSTIC FIBROSIS AND DUCHENNE MUSCULAR DYSTROPHY
Privolnev, Y.
Cox, J.
Breen, M.
Reyes, A.
[J]. VALUE IN HEALTH, 2018, 21 : S459 - S459
[5] IS THE REIMBURSEMENT OF ORPHAN MEDICAL PRODUCTS FULLY OPTIMISED IN ENGLAND AND WALES?
Hendrich, J.
[J]. VALUE IN HEALTH, 2019, 22 : S843 - S843
[6] NOVEL DRUG REIMBURSEMENT MODELS: LESSONS AND IMPLICATIONS FROM CANCER DRUG ACCESS SCHEMES
Aggarwal, S.
[J]. VALUE IN HEALTH, 2011, 14 (07) : A361 - A361
[7] EMERGING DRUG REIMBURSEMENT MODELS: LESSONS AND IMPLICATIONS FROM CANCER DRUG ACCESS SCHEMES
Aggarwal, S.
[J]. VALUE IN HEALTH, 2012, 15 (07) : A298 - A299
[8] Orphan drug development: The impact of regulatory and reimbursement frameworks
Huang, Yu-Jun
Chao, Wan-Yu
Wang, Chi-Chuan
Chang, Lin-Chau
[J]. DRUG DISCOVERY TODAY, 2022, 27 (06) : 1724 - 1732
[9] THE EXPENDITURE AND REIMBURSEMENT OF ORPHAN DRUG IN TAIWAN: CHALLENGES AND OPPORTUNITIES
Chiang, P.
Yang, W.
[J]. VALUE IN HEALTH, 2016, 19 (03) : A255 - A255
[10] Orphan Drug Pricing and Reimbursement Policies Lacking in EU
不详
[J]. PHARMACEUTICAL MEDICINE, 2018, 32 (04) : 297 - 298

← 1 2 3 4 5 →